These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 35348293

  • 1. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
    Liu J, Jiang K.
    J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X, Zhang Z, Wang L, Zhang S, Ren L, Li S, Xu J, Lv S.
    Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
    [Abstract] [Full Text] [Related]

  • 3. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S, Lu X, Zheng D, Chen W, Li Y, Li F.
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [Abstract] [Full Text] [Related]

  • 4. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
    Huang Y, Guan Y, Zhang X.
    Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409
    [Abstract] [Full Text] [Related]

  • 5. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
    Ye K, Li L, Wu B, Wang D.
    Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
    [Abstract] [Full Text] [Related]

  • 6. METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.
    Gong Y, Jiang Q, Liu L, Liao Q, Yu J, Xiang Z, Luo X.
    Physiol Genomics; 2022 Sep 01; 54(9):337-349. PubMed ID: 35759451
    [Abstract] [Full Text] [Related]

  • 7. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G, Liu J, Wang Y, Liu H, Fu J, Zhao Y, Huang Y.
    Environ Toxicol; 2023 Oct 01; 38(10):2377-2390. PubMed ID: 37449729
    [Abstract] [Full Text] [Related]

  • 8. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.
    Bao J, Xu T, Wang W, Xu H, Chen X, Xia R.
    Mol Cell Biochem; 2024 Nov 01; 479(11):3077-3089. PubMed ID: 38180718
    [Abstract] [Full Text] [Related]

  • 9. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
    Zhang F, Yan Y, Cao X, Zhang J, Li Y, Guo C.
    Aging (Albany NY); 2021 Apr 21; 13(8):12224-12238. PubMed ID: 33882457
    [Abstract] [Full Text] [Related]

  • 10. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Gong Y, Luo G, Zhang S, Chen Y, Hu Y.
    Cell Signal; 2024 May 21; 117():111068. PubMed ID: 38286198
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.
    Zhang QC.
    Kaohsiung J Med Sci; 2023 Mar 21; 39(3):266-277. PubMed ID: 36546578
    [Abstract] [Full Text] [Related]

  • 14. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
    Bi X, Lv X, Liu D, Guo H, Yao G, Wang L, Liang X, Yang Y.
    Cancer Gene Ther; 2021 Apr 21; 28(3-4):335-349. PubMed ID: 32939058
    [Abstract] [Full Text] [Related]

  • 15. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
    Wang D, Wang X, Huang B, Zhao Y, Tu W, Jin X, Shao Y, Zhu Y, Lu G.
    Andrologia; 2022 Aug 21; 54(7):1581-1591. PubMed ID: 35413135
    [Abstract] [Full Text] [Related]

  • 16. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
    Qian K, Xu W, Xia X, Ding J.
    Genes Genomics; 2022 Dec 21; 44(12):1519-1530. PubMed ID: 36040683
    [Abstract] [Full Text] [Related]

  • 17. METTL3 promotes choriocarcinoma progression by activating the miR-935/GJA1 pathway in an m6A-dependent manner.
    Wang W, Shi J, Zheng L.
    Am J Reprod Immunol; 2023 Nov 21; 90(5):e13791. PubMed ID: 37881126
    [Abstract] [Full Text] [Related]

  • 18. Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2.
    Chen X, Zhang X, Qian Y, Xia E, Wang Y, Zhou Q.
    Cell Cycle; 2022 May 21; 21(10):1058-1076. PubMed ID: 35184686
    [Abstract] [Full Text] [Related]

  • 19. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox.
    Zhou Y, Li W.
    Environ Toxicol; 2024 Mar 21; 39(3):1631-1640. PubMed ID: 38018881
    [Abstract] [Full Text] [Related]

  • 20. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M, Zhai X, Chen Y, Yin D.
    Pathol Res Pract; 2024 Aug 21; 260():155437. PubMed ID: 38959625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.